The Food and Drug Administration is expected to grant emergency authorization to Pfizer’s COVID-19 vaccine for 12- to 15-year-olds within the week. If that occurs, it will be the first shot authorized for this group of younger teens.
Now that the U.S. is getting close to authorizing the first COVID-19 vaccine for younger teens, it will pave the way for immunizations to begin to reach a broader group of Americans at a time when the pace of vaccinations is slowing.